Legal & General Group PLC Arrowhead Pharmaceuticals, Inc. Transaction History

Legal & General Group PLC

$423 Billion
Q1 2024

A detailed history of Legal & General Group PLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 274,050 shares of ARWR stock, worth $7.01 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

274,050

Previous 274,050 -0.0%

Holding current value

$7.01 Million

Previous $7.84 Million -0.0%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$27.21 - $39.48 $43,182 - $62,654	-1,587 Reduced 0.58%	274,050 $7.84 Million
Q4 2023 Feb 15, 2024	BUY	$21.2 - $31.03 $1.21 Million - $1.77 Million	57,167 Added 26.17%	275,637 $8.43 Million
Q3 2023 Nov 14, 2023	SELL	$26.2 - $36.08 $118,031 - $162,540	-4,505 Reduced 2.02%	218,470 $5.87 Million
Q2 2023 Aug 14, 2023	SELL	$25.16 - $41.38 $223,622 - $367,785	-8,888 Reduced 3.83%	222,975 $7.95 Million
Q1 2023 May 15, 2023	SELL	$23.68 - $38.51 $1.12 Million - $1.83 Million	-47,478 Reduced 17.0%	231,863 $5.89 Million

Q4 2022 Feb 14, 2023	BUY	$28.0 - $40.56 $340,704 - $493,534	12,168 Added 4.55%	279,341 $11.3 Million
Q3 2022 Nov 14, 2022	SELL	$29.63 - $48.31 $48,119 - $78,455	-1,624 Reduced 0.6%	267,173 $8.83 Million
Q2 2022 Aug 22, 2022	BUY	$27.79 - $50.61 $365,549 - $665,723	13,154 Added 5.15%	268,797 $9.47 Million
Q1 2022 May 16, 2022	BUY	$39.62 - $69.97 $1.11 Million - $1.95 Million	27,937 Added 12.27%	255,643 $11.8 Million
Q4 2021 Feb 14, 2022	BUY	$58.09 - $82.51 $212,667 - $302,069	3,661 Added 1.63%	227,706 $15.1 Million
Q3 2021 Nov 15, 2021	BUY	$58.38 - $84.96 $1.36 Million - $1.98 Million	23,310 Added 11.61%	224,045 $14 Million
Q2 2021 Aug 12, 2021	SELL	$62.15 - $90.32 $5.47 Million - $7.95 Million	-87,997 Reduced 30.48%	200,735 $16.6 Million
Q1 2021 May 17, 2021	BUY	$61.35 - $90.47 $2.39 Million - $3.52 Million	38,953 Added 15.59%	288,732 $19.1 Million
Q4 2020 Feb 12, 2021	BUY	$43.82 - $85.37 $342,497 - $667,251	7,816 Added 3.23%	249,779 $19.2 Million
Q3 2020 Nov 13, 2020	SELL	$33.21 - $51.27 $66,121 - $102,078	-1,991 Reduced 0.82%	241,963 $10.4 Million
Q2 2020 Aug 14, 2020	BUY	$26.12 - $43.27 $2.71 Million - $4.49 Million	103,851 Added 74.12%	243,954 $10.5 Million
Q1 2020 May 14, 2020	SELL	$20.56 - $63.12 $14,165 - $43,489	-689 Reduced 0.49%	140,103 $4.03 Million
Q4 2019 Feb 13, 2020	SELL	$28.14 - $73.01 $3.77 Million - $9.77 Million	-133,870 Reduced 48.74%	140,792 $8.93 Million
Q3 2019 Nov 13, 2019	BUY	$26.26 - $34.86 $1.34 Million - $1.78 Million	51,159 Added 22.89%	274,662 $7.74 Million
Q2 2019 Aug 14, 2019	BUY	$17.43 - $28.82 $3.59 Million - $5.93 Million	205,780 Added 1161.09%	223,503 $5.92 Million
Q1 2019 May 15, 2019	BUY	$12.05 - $20.18 $28,136 - $47,120	2,335 Added 15.17%	17,723 $325,000
Q4 2018 Feb 15, 2019	BUY	$10.74 - $19.7 $17,377 - $31,874	1,618 Added 11.75%	15,388 $191,000
Q2 2018 Aug 10, 2018	BUY	$6.37 - $14.02 $87,714 - $193,055	13,770 New	13,770 $188,000

Others Institutions Holding ARWR

# of Institutions

296

Shares Held

88.5M

Call Options Held

905K

Put Options Held

387K

View Full List

About ARROWHEAD PHARMACEUTICALS, INC.

Ticker ARWR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,849,000
Market Cap $2.71B
Description
Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...

More about ARWR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Arrowhead Pharmaceuticals, Inc. Transaction History